Dr. Judy Jays

• Pharmaceutical Chemistry
• Synthetic Chemistry
• Computational Chemistry

• Developing an analytical method and validation for estimation of residual solvents in Gliclazide using Gas Chromatography. Challenges and Advances in Pharmaceutical Research Vol. 9

• Biju Joseph Memorial Endowment Merit Award - memento and cash Prize of 10,000 by Knanaya Arch diocese in 2022
• Annual Exemplary Faculty award - memento and cash Prize of 10,000 - from RUAS including on teachers day celebrations September 6, 2021
• BEST RESEARCHER award from Royal Society of Chemistry, London along with 1-year subscription of ‘Analyst‘ at International Conference On Molecular Structure and Instrumental Approaches. 26-27 November, 2020.
• “Best Oral Presentation award” for International Conference On Emerging Strategies In Antimicrobial Agents And Bio-Innovations held at RK University on 18-19 December, 2020
• “Outstanding professor of RUAS” award by RUAS in February 2020
• “Women Excellence” award by Goluka Education foundation (2012)
• Best Teacher Performer 2012 – Q.A. audit by students & peers evaluation: Appreciation by the Chief Executive, Gokula Education Foundation (Medical)

International Conferences

• Judy Jays “Synthesis, in silico molecular docking, ADME prediction and biological evaluation of some novel isoxazoles as plausible inhibitors of S. aureus” International Conference on Recent Advances on Green and Sustainable Developments by Akal University on 6th -8th September 2023
• Devika Murileedharan, Parashuram P, Judy Jays. “Unlocking Therapeutic potential: Targeted inhibition of diabetic nephropathy through molecular docking and pharmacophore mapping.”4th World Congress on Drug Discovery and Development-2023 by Biogenesis Health Cluster held on 29th October 2023
• Anjana Srivatsa, Judy Jays. “Bioluminescent algae as potential biomarkers for avoiding subsequent myocardial infarction”.4th World Congress on Drug Discovery and Development-2023 by Biogenesis Health Cluster held on 29th October 2023
• Protyusha Maji, Judy Jays "Discovering Innovative Cardiovascular Therapies through Molecular Docking and Pharmacophore Mapping. 4th World Congress on Drug Discovery and Development-2023 by Biogenesis Health Cluster held on 29th October 2023
• Madhushree K, Judy Jays “Design of novel amino-pyrimidines as GABA amino transferase inhibitors to treat convulsions. International conference on innovations and advances in Pharmaceutical sciences by Adichunchungiri University on 10-11th February 2023
• Devraj Uppar. Judy Jays. Novel molecule identification of UNC-51 like kinase 1 (ULK-1) role in heart regeneration via Autophagy. Third international congress on biological and health sciences on 14-16th April 2023 by International congress on biological and health sciences.
• Judy Jays, Parasuram P, Saravanan J. Screening of Some Novel Isoxazoles Against C. Albicans for their Potential Use as antifungals: A Computational Approach International Conference on Current Trends in Drug Discovery Development & Delivery (CTD4-2022), by KL University on 21st—22nd October 2022
• Judy Jays, Saravanan J “Molecular docking studies and binding site interactions of some novel isoxazoles against the target enzymes of E.coli.” E-World Congress On Science, Technology, Engineering & Management “Think Beyond Covid-19,Non-Communicable Diseases” organized by Biogenesis Health cluster conferences, Bengaluru, on 2nd October 2022
• G Chaitanya Sai, Judy Jays. “Molecular Docking and ADMET studies of Pyrazole derivatives at 2nd World congress of Pharmacology-Drug Discovery and development by Biogenesis Health Cluster, Bengaluru on 30th January, 2022
• Aiswarya Raju, Judy Jays. “In-Silico Molecular Docking And ADMET Prediction Studies of Novel Furan-Azetidinone Hybrids As Potent Inhibitors of S.aureus” in SSX-2021 Virtual conference held from 14th to 17th July 2021
• Aiswarya Raju, Judy Jays. “Molecular Docking Studies of Novel Furan-Azetidinone Hybrids as Potent Inhibitors of Candida Albicans” at the International Conference on Bioinformatics, Computational Biology, and Biomedical Science (ICBCBBS-2021) from 15th – 16th May, 2021.
• Judy Jays, S Mohan, J Saravanan. In-silico molecular docking and ADME studies of some novel amino-pyrimidines as prospective inhibitors of S. Aureus. International Conference On Emerging Strategies In Antimicrobial Agents And Bio-Innovations 18th -19th December 2020
• Judy Jays, S Mohan, J Saravanan. In-silico molecular docking studies of some novel Isoxazoles as potential inhibitors of S. Aureus. International conference on molecular structure and instrumental approaches. 26th -27th November 2020
• Judy Jays, S Mohan, J Saravanan. In silico molecular docking studies and binding site interactions of some aminopyrimidines against the target enzymes of Escherichia Coli. PESCP 6th International Conference October 2019
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of some novel furan derivatives as potent inhibitors of Escherichia Coli. INNOPHARM3- 3rd international conference on academic and industrial innovations. Goa, October 2018
• Vijaybhanu P, Knolin K Thachil, Judy Jays. Molecular docking studies of novel coumarino pyrazolinone derivatives as potent antifungal agents. INNOPHARM3- 3rd international conference on academic and industrial innovations. Goa, October 2018
• Knolin K.Thachil, Vijaybhanu P, Judy Jays. Design and molecular docking studies of novel hybrid molecules of benzoxazinyl pyrazole arylidenes as antifungal agents. INNOPHARM3- 3rd international conference on academic and industrial innovations. Goa, October 2018
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies and ADME prediction of novel chalcones as potential antibacterial agents. 3rd International conference ICCI-SEM July 2017
• Judy Jays, S Mohan, J Saravanan. Synthesis and biological evaluation of some novel schiff bases. PESCP International Conference October 2015.

National Conferences

• Pradan P Jain, Judy Jays. ‘Design, molecular Docking studies, synthesis and characterization of some novel furan derivatives for potential anticancer activity.’ Drug Design and evaluation: Current scenario organized by RR College of Pharmacy in association with Karnataka State Pharmacy Council on 30th September 2023
• Madhushree K, Judy Jays. In-silico study of Amino-pyrimidine derivatives for potential anti-bacterial activity. National conference on Drug delivery and translational research.17th March 2023
• Judy Jays “Molecular docking studies and in-silico pharmacokinetic predictions of some novel amino-pyrimidines as potential inhibitors of E.coli.” E-Symposium on Integrated Approaches to Drug Discovery and Development – An Update organized by Manipal College of Pharmaceutical Sciences, MAHE, Manipal from 25th to 27th July 2022
• Devraj U, Judy Jays. Role of sodium –glucose cotransporter-2 (SGLT-2) inhibitors in cardiac failure & chronic kidney disease in type-2 diabetes: A computational approach. National conference on Drug Discovery and In-Silico drug design. 18th November 2022
• Madhushree K, Judy Jays “Potent lead identification against Xanthine oxidase: A computational approach” National conference on Drug Discovery and In-Silico drug design by Royal College of Pharmacy on 18th November 2022
• Burhaniddin Madriwala, Judy Jays. “Molecular docking and computational Pharmacokinetic study of flavonoid analogues tethered with Isoniazid for antitubercular activity” at National conference on Multi-disciplinary research in Pharmaceutical sciences by SRM University from 9-11th February, 2022.
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of some novel aminopyrimidines as potential inhibitors of Candida Albicans. Indian council of chemists –ICC conference, Surathkal, December 2018.
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of novel furan-azetidinone hybrid compounds as potent antifungal agents. Biosci conference, Goa, June 2018
• Vijaybhanu P, Judy Jays, Knolin K.Thachil. Molecular docking studies of novel coumarino pyrazolinone derivatives as potent antibacterial agents. Biosci conference, Goa, June 2018
• Knolin K.Thachil, Judy Jays, Vijaybhanu P. Molecular docking studies and ADME prediction of novel hybrid molecules of benzoxazinyl pyrazole arylidenes. Biosci conference, Goa, June 2018
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies and ADME prediction of novel furan derivatives as potent antibacterial agents. ALPHACON- Feb 2017
• Judy Jays, Raju K, C.H.S. Venkataramana. Synthesis and biological evaluation of some novel heterocyclic derivatives of paracetamol as potential antimicrobial agents. 1st Pharmaceutical Science Congress March 2017
• Judy Jays, S Mohan, J Saravanan. Synthesis, characterization and antimicrobial evaluation of some novel schiff bases of 2-amino furan.67th IPC, Mysuru, December 2015

Publications

• Enugurthi Hari Krishna, Kamatchi Sundara Saravanan, Judy Jays. Ziziphus rugosa Leaves: Pharmacognostical Characters and Anti-Inflammatory Properties against Carrageenan-Induced Paw Edema. Borneo Journal of Pharmacy, 7 (1): 89-103. (2024)
• Judy Jays, J Saravanan A molecular modelling approach for structure-based virtual screening and identification of novel isoxazoles as potential antimicrobial agents against s. aureus International Journal of Pharmacy and Pharmaceutical sciences, 16(4), pp. 36-41. (2024)
• Judy Jays, P Parasuram, J Saravanan. Screening of Some Novel Isoxazoles Against C. Albicans for their Potential Use as antifungals: A Computational Approach. Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). https://doi.org/10.1039/9781837671090-00103
• Lairikyengbam Deepti Roy, Jyotsna Kumar, Judy Jays, Geeta Krishnamurthy, Pooja Gour, Shivanjali Esther Arland. Novel resveratrol analogues with aromatic hetero moieties: designing, one-pot synthesis and in vitro biological evaluation. Farmacia, 71(1) (2023)
• Aiswarya Raju, Judy Jays. In-Silico molecular docking studies, synthesis and biological evaluation of novel Furan-Azetidinone hybrids as potential anti-cancer agents. International Journal of Pharmaceutical Sciences and Research, 13(7), pp. 2759-2764. (2022)
• Burhaniddin Madriwala, Judy Jays. Analytical method development and validation for estimation of residual solvents in Gliclazide using Gas Chromatography”. International Journal of current Pharmaceutical Research, 14(4), pp. 68-73. (2022)
• Burhaniddin Madriwala, Judy Jays, Suma BV. Molecular docking study of Hentriacontane for anticancer and antitubercular activity. International journal of chemistry research, 6(4), pp.1-4 (2022)
• G. Chaitanya Sai, Judy Jays, Burhannudin Madriwala. Design, Binding affinity studies and In-silico ADMET predictions of novel isoxazoles as potential anti-bacterials. International Journal of current Pharmaceutical Research, 14(4), pp. 74-77. (2022)
• Burhaniddin Madriwala, Judy Jays, G. Chaitanya Sai. Molecular Docking and computational pharmacokinetic study of some novel coumarin-Benzothiazole Schiff bases for antimicrobial activity. International Journal of Pharmacy and Pharmaceutical sciences, 14(8), pp. 16-21. (2022)
• Ankita K, Divya S, Suma KB, Everlyse F, Judy Jays, Manikanta Murahari. Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis. Journal of Molecular Graphics and Modelling. 101 (2020) 107718
• Sharon CF, Bharath S and Judy Jays. In Silico Prediction and In Vivo Wound Healing Indicators of Nano Chitin Incorporated Lyophillised Alginate Matrices. Conference on drug design and discovery technologies. Conference proceedings. October 21-22, 2019
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of some novel furan–azetidinone hybrid compounds as potential inhibitors of Escherichia coli. Indian Journal of Pharmaceutical Education and Research 53(3), S325-S331. (2019)
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of some novel furan–azetidinone hybrid compounds as potential antifungal agents International Research Journal of Pharmacy 10(2), 157-160. (2019)
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of some novel furan derivatives as potent inhibitors of Staphylococcus Aureus. International Journal of Pharmaceutical Research, 11(1), 200-206. (2019)
• Judy Jays, S Mohan, J Saravanan. Molecular docking studies of novel aminopyrimidines as potent antifungal agents. Chemical methodologies, 3(4), 442-450. (2019)
• Vijay Bhanu P, Judy Jays, Knolin K Thachil. Molecular docking studies of novel coumarino pyrazolinone derivatives as potent antibacterial agents. International Journal of Pharmacy & Therapeutics 10(3), 70-73. (2019)
• Knolin K.Thachil, Judy Jays, Vijaybhanu P. Molecular docking studies and ADME prediction of novel hybrid molecules of benzoxazinyl pyrazole arylidenes. International Journal of Pharmacy & Therapeutics, 10(3), 74-78. (2019)
• Judy Jays, S Mohan, J Saravanan. Synthesis, characterization and antimicrobial screening of some novel furan-azetidinone hybrid compounds. International Journal of Pharma and Biosciences Jan, 9(1), 79-87. (2018)
• B.V. Suma, N N Natesh, C.H.S. Venkataramana, Judy Jays and V. Madhavan Synthesis and antibacterial of some new 1, 2, 3 benzotriazoles derivatives containing pyrazolidinedione moieties. International Journal of Pharmacy and Pharmaceutical Sciences, 4(1), 169-173. (2012)
• Judy Jays, Ankit K. Rochani, Amit Kumar, B.V. Suma, C.H.S. Venkataramana, and V. Madhavan In silico ADME and toxcity studies of some synthesized novel isatin derivatives. Int J Pharma Bio Sci, 2(4), 25-33. (2011)
• Ankit K. Rochani, B.V. Suma, C.H.S. Venkataramana, and Judy Jays. Drug design and In-Silico Hepatotoxicity studies of Synthesized Novel 4-Quinolone containing Pyrazolidinedione derivatives. Int.J.ChemTech Res, 3(3), 1668-1680. 2011
• Judy Jays, Amit Kumar, C.H.S. Venkataramana, B.V. Suma, and V. Madhavan Synthesis and Biological Evaluation of some New 2-(2-Methyl-5-Nitro-1H-Imidazol-1-yl)-N'-[(3Z)-2-Oxo-1,2-Dihydro-3H-Indol-3-ylidene]Acetohydrazide derivatives. Int.J. ChemTech Res, 3(2), 772-777. 2011
• B.V. Suma, Ankit K. Rochani, C.H.S. Venkataramana, Judy Jays and V. Madhavan Synthesis, Characterization, invitro Antibacterial, Anti-inflammatory Evaluations of Novel 4-Quinolone containing Pyrazolidinedione derivatives. Int.J. ChemTech Res, 2(4). 2156-2162. 2010
• Ankit K. Rochani, B.V. Suma, Surendar Kumar, Judy Jays and V. Madhavan. QSAR, ADME and QSTR studies of some synthesized anti-cancer 2-indolinone derivatives. Int J Pharma Bio Sci, 1(4), 208-218. 2010
• B.V. Suma, Surendar Kumar, Judy Jays C.H.S. Venkataramana, and V. Madhavan Synthesis and Biological Evaluation of some New 2-(1h-Benzotriazolyl-1-yl) Acetohydrazide containing Isatin derivatives. Am. J. PharmTech Res, 2(3), 558-567. (2010)

• KSPC (Karnataka State Pharmacy Council)
• APTI (Association of Pharmaceutical Teachers of India)
• PCI (Pharmacy Council of India)
• ICC (Indian Council of Chemists)

• 01